Keywords: merck, co, proscar, cuts, prostate, cancer, risk

Merck & Co's Proscar cuts prostate cancer risk

Article | 30 June 2003

Print This

Merck & Co's Proscar (finasteride), a drug indicated for the treatment of male pattern baldness and benign prostatic hyperplasia, may also ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in